Professor Sham is the Associate Vice President (Research) of the University of Hong Kong. She assists the university senior management team in developing the University’s research in Hong Kong and mainland China, research integrity policy and education, as well as enhancing the quality of research postgraduate education.
• Technical Advisor to International Atomic Energy Agency, Vienna, Austria.
• Ex-Professor and Head, Department of Preventive Oncology and Head, WHO Collaborative Centre for Cancer Prevention, Screening and Early Detection at the Tata Memorial Centre, Mumbai
• His main areas of interest are cervical, breast and tobacco attributed cancers and has published in leading Journals including Nature, Lancet, Lancet Oncology, NEJM, JNCI and IJC. He has also contributed to several reviews and guidelines on these cancers published by the World Health Organization and American Society of Clinical Oncology.
Dr. Ted Rohr is Director of Research Ethics & Compliance Support at UNSW Sydney. In this role he is responsible for the university’s operations of research involving humans, animals, gene technology, radiation, controlled goods and technology, drones and quarantine. Ted has held senior roles in the fields of research integrity and ethics at La Trobe University and RMIT University in Melbourne since 2006.
Dr. Michael Cheng-Tek Tai is a chair professor of bioethics and medical humanities of the Institute of Medicine, Chungshan Medical Univeristy, Taichung, Taiwan. Dr. Tai earned his Ph.D. in Comparative Ethics from Concordia University in Montreal, Canada and had taught at Concordia University, Montreal, King College, Bristol, Tennessee and University of Saskatchewan, Saskatoon, Canada before his return to Taiwan in 1997. Since then he had served the dean of the College of Medical Humanities and Social Sciences and the chairman of the department of Social Medicine of the Chungshan Medical University.
Iekuni Ichikawa graduated from Keio University School of Medicine, Japan in 1972. After his pediatric residency, he began his nephrology fellowship training at the University of California, San Francisco, and completed it at Harvard Medical School. He remained at Harvard and the Children’s Hospital as an instructor in medicine and then an associate professor of pediatrics until he moved to Vanderbilt University as the Head of the Division of Pediatric Nephrology.
